Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03620201
Title M7824 in Treating Patients With Stage II-III HER2 Positive Breast Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

Her2-receptor positive breast cancer

Therapies

M7824

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.